111 related articles for article (PubMed ID: 4135044)
21. Modified sequential oral contraception employing mestranol with chlormadinone.
Tyler ET; Matsner EM; Gotlib M
Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
[No Abstract] [Full Text] [Related]
22. [Use of Ovosiston in prevention of bleeding after electroconization].
Malachowski Z; Kaliński R
Pol Tyg Lek; 1970 Jul; 25(30):1138-9. PubMed ID: 4194911
[No Abstract] [Full Text] [Related]
23. [Porphyria cutanea tarda caused by long-term use of femigen].
Chowaniec O; Wierzbieta J
Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
[TBL] [Abstract][Full Text] [Related]
24. [Experiences with the different dosage of Ovosiston preparations in the framework of marital and sexual counseling. Individual therapy with oral contraceptives].
Ebeling K; Kühndel K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(2):61-4. PubMed ID: 4106277
[No Abstract] [Full Text] [Related]
25. [Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
Steindel E; Mohnike A; Langreck G
Z Arztl Fortbild (Jena); 1971 Feb; 65(3):159-61. PubMed ID: 4102493
[No Abstract] [Full Text] [Related]
26. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
Keil G
Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
[No Abstract] [Full Text] [Related]
27. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation].
Spirov G; Vetsova N
Vestn Dermatol Venerol; 1975 Feb; (2):57-8. PubMed ID: 50675
[No Abstract] [Full Text] [Related]
28. [Gestranol in treatment of excessive postpartum breast intumescence].
Ostrzeński A
Pol Tyg Lek; 1974 Mar; 29(12):489-90. PubMed ID: 4132234
[No Abstract] [Full Text] [Related]
29. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
Bernard I
Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
[No Abstract] [Full Text] [Related]
30. [Experience with Ovosiston for contraception. II].
Geschke H
Dtsch Gesundheitsw; 1970 Feb; 25(5):201-6. PubMed ID: 4192921
[No Abstract] [Full Text] [Related]
31. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
Krzywdziński K; Jedrzejewski M; Teter J
Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
[No Abstract] [Full Text] [Related]
32. [Effect of chlormadinone and chlormadinone with mestranol on the liver function].
Marcinkowski Z
Ginekol Pol; 1978 Jun; 49(6):525-30. PubMed ID: 80353
[No Abstract] [Full Text] [Related]
33. Bile acid metabolism in mammals. I. Bile acid-induced intrahepatic cholestasis.
Fisher MM; Magnusson R; Miyai K
Lab Invest; 1971 Jul; 25(1):88-91. PubMed ID: 5555699
[No Abstract] [Full Text] [Related]
34. [Drug-induced intrahepatic cholestasis with lethal outcome after methyltestosterone].
Nielsen JA
Ugeskr Laeger; 1970 Nov; 132(46):2173-6. PubMed ID: 5487343
[No Abstract] [Full Text] [Related]
35. [Treatment of seborrheic conditions of the female scalp using modern combined peroral estrogen-gestagen preparations].
Spirov G; Berova N; Vasilev D
Vestn Dermatol Venerol; 1973 Jul; 47(7):30-3. PubMed ID: 4127925
[No Abstract] [Full Text] [Related]
36. Effect of sequential mestranol-chlormadinone on sebum production.
Pochi PE; Strauss JS
Arch Dermatol; 1967 Jan; 95(1):47-9. PubMed ID: 4163188
[No Abstract] [Full Text] [Related]
37. [Drug-induced icterus caused by chloroquine].
Klemm G
Z Gesamte Inn Med; 1970 Apr; 25(8):374-6. PubMed ID: 5523265
[No Abstract] [Full Text] [Related]
38. [Contraceptive steroids and serum lipids].
Magos C
Ginecol Obstet Mex; 1972 Nov; 32(193):509-11. PubMed ID: 4117797
[No Abstract] [Full Text] [Related]
39. [Medical therapy of acne vulgaris].
Naerup JG
Tidsskr Nor Laegeforen; 1968 Apr; 88(7):650. PubMed ID: 4175244
[No Abstract] [Full Text] [Related]
40. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
Krause W; Böhm W; Müller W
Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
